Literature DB >> 21039851

Coronary artery bypass graft for anomalous right coronary artery.

Bobby Yanagawa1, Abdullah A Alghamdi, Robert B Chen, Anthony Amankwaa, Subodh Verma.   

Abstract

A 27-year-old man with anomalous right coronary artery (RCA) presented with ventricular fibrillatory arrest. Computed tomography angiography revealed an anomalous RCA arising from the left sinus of Valsalva with an acute angulation at the coronary takeoff and compressed interarterial segment. This patient underwent a short saphenous vein coronary artery bypass graft to the proximal RCA and recovered uneventfully. A review of the literature and discussion of the surgical management is presented.
© 2010 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2010        PMID： 21039851     DOI： 10.1111/j.1540-8191.2010.01116.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN： 0886-0440            Impact factor:   1.620


  4 in total

1.  Is endovascular therapy the right choice for treatment of functional compression of anomalous right coronary artery arising from left coronary sinus with interarterial course?

Authors:  Ramalingam Vadivelu; Shiv Bagga
Journal:  BMJ Case Rep       Date:  2013-01-28

2.  An Infected Bicuspid Aortic Valve, an Anomalous Coronary Artery, and a Dog-Bitten Postman.

Authors:  Marliza O'Dwyer; Julie-Anne Houlihan; Sadhbh O'Rourke; Vincent Young; Brian O'Connell
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

3.  Three different situations and approaches in the management for anomalous origin of the right coronary artery from the left coronary sinus: case report.

Authors:  Woon Heo; Ho-Ki Min; Do Kyun Kang; Hee Jae Jun; Youn-Ho Hwang; Hyung Chae Lee
Journal:  J Cardiothorac Surg       Date:  2014-01-23       Impact factor: 1.637

Review 4.  Surgical Techniques for the Treatment of Anomalous Origin of Right Coronary Artery From the Left Sinus: A Comparative Review.

Authors:  Lara Gharibeh; Kenza Rahmouni; Seok Joon Hong; Andrew M Crean; Juan B Grau
Journal:  J Am Heart Assoc       Date:  2021-11-02       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.